Business Context and Reporting Period
This Form 8-K is filed by Xcyte Therapies, Inc. (not Bio Green Med Solution, Inc.) for the reporting period of October 24, 2005. The filing addresses the termination of a material definitive agreement related to equipment financing.
Key Financial Metrics
- Debt Repayment: The company paid $1,807,778 to Oxford Finance Corporation to satisfy obligations under a Master Security Agreement dated July 1, 2003.
- Liquidity Impact: The payment was made to remove a security interest on specific equipment, thereby increasing asset flexibility.
- Revenue and Profit: The filing text does not provide a clear value for revenue, profit, or operating margins.
Material Changes
The primary material change is the full prepayment of obligations to Oxford Finance Corporation. This action terminated the Master Security Agreement and resulted in the release of all security interests held by Oxford on the financed equipment. This change was executed to provide flexibility for the company's review of strategic alternatives.
Outlook and Management Commentary
Management indicated that the prepayment was a strategic move to facilitate a previously announced review of strategic alternatives. There are no material relationships between Xcyte and Oxford beyond the terminated agreement. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the context of the strategic review.
Investor Verification Checklist
- Verify the company's current cash position following the $1.8 million debt repayment.
- Confirm the status and timeline of the "review of strategic alternatives" mentioned in the filing.
- Ensure the release of the security interest on the equipment has been formally recorded.
- Note the discrepancy between the requested company name (Bio Green Med Solution, Inc.) and the actual registrant (Xcyte Therapies, Inc.).